Pictet Asset Management
EW icon

Pictet Asset Management’s Edwards Lifesciences EW Stock Holding History

Pictet Asset Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.9M Sell
330,871
-12,145
-4% -$1.02M 0.03% 435
2026
Q1 		$27.5M Sell
343,016
-9,200
-3% -$758K 0.03% 433
2025
Q4 		$30M Sell
352,216
-5,900
-2% -$484K 0.03% 426
2025
Q3 		$27.8M Sell
358,116
-143,444
-29% -$11.2M 0.03% 452
2025
Q2 		$39.2M Buy
501,560
+39,044
+8% +$2.91M 0.04% 357
2025
Q1 		$33.5M Buy
462,516
+86,771
+23% +$6.21M 0.04% 380
2024
Q4 		$27.8M Buy
375,745
+26,573
+8% +$1.86M 0.03% 415
2024
Q3 		$23M Buy
349,172
+8,311
+2% +$604K 0.03% 455
2024
Q2 		$31.5M Buy
340,861
+5,135
+2% +$455K 0.04% 364
2024
Q1 		$32.1M Sell
335,726
-13,668
-4% -$1.15M 0.03% 384
2023
Q4 		$26.6M Sell
349,394
-628,357
-64% -$43.7M 0.03% 410
2023
Q3 		$67.7M Buy
+977,751
New +$78.6M 0.08% 237

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Pictet Asset Management's EW Position: Q2 2026 in Review

Pictet Asset Management reduced its Edwards Lifesciences (EW) stake by 3.5% in Q2 2026, selling an estimated $1.02M and leaving 330,871 shares worth $29.9M. The position accounts for 0.03% of the portfolio, ranked #435.

Pictet Asset Management first reported a position in EW in Q3 2023 and has held it in 12 quarters since. The position peaked at $67.7M in Q3 2023. 1,338 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Pictet Asset Management held 330,871 shares of Edwards Lifesciences worth $29.9M as of Q2 2026.
  • Pictet Asset Management sold 12,145 Edwards Lifesciences shares in Q2 2026, an estimated $1.02M.
  • Edwards Lifesciences made up 0.03% of Pictet Asset Management's portfolio in Q2 2026, its #435 holding.
  • Pictet Asset Management first reported a position in Edwards Lifesciences in Q3 2023 and has held it in 12 quarters since.
  • Pictet Asset Management's Edwards Lifesciences position peaked at $67.7M in Q3 2023.
  • 1,338 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.